According to Roche's latest financial reports the company's current EPS (TTM) is $23.29. In 2022 the company made an earnings per share (EPS) of $23.29 a decrease over its 2021 EPS that were of $24.85.
Year | EPS | Change |
---|---|---|
2022 | $23.29 | -6.29% |
2021 | $24.85 | -5.53% |
2020 | $26.31 | 16.56% |
2019 | $22.57 | 30.3% |
2018 | $17.32 | 20.22% |
2017 | $14.41 | -5.81% |
2016 | $15.30 | 4.62% |
2015 | $14.62 | -5.13% |
2014 | $15.41 | -25.05% |
2013 | $20.56 | 21.73% |
2012 | $16.89 | 3.82% |
2011 | $16.27 | 8.16% |
2010 | $15.04 | 23.72% |
2009 | $12.16 | -12.31% |
2008 | $13.86 | -0.34% |
2007 | $13.91 | 32.13% |
2006 | $10.53 | 42.56% |
2005 | $7.39 | -22.7% |
2004 | $9.55 | 132.85% |
2003 | $4.10 | -154.73% |
2002 | -$7.50 | -209.09% |
2001 | $6.87 | -57.25% |
2000 | $16.07 | 54.06% |
1999 | $10.43 | 31.24% |
1998 | $7.95 |